Body Handbook Catalogue Profile Ranking
Healthcare BODY HANDBOOK
Healthcare ยท ยง638
Menopausal Hormone Therapy (MHT)
Around age fifty-one the ovaries stop, and estrogen, which ran sleep, mood, bone, blood vessels, and vaginal tissue, falls by about ninety-five percent. One 2002 trial scared a generation of doctors off replacing it, but it enrolled women a median twelve years past menopause. Here's what you didn't know you didn't know: for a symptomatic woman under sixty, hormone therapy is one of the highest-value prescriptions in medicine, and the 2025 FDA panel is reconsidering the warning label. Timing is the whole story.
Decide ยท Daily Evidence Moderate Chapter Healthcare

Hot flashes and night sweats last a median seven and a half years, far longer than most women are told 1. An adequate estrogen dose clears about three-quarters of them within weeks 2.

Started within ten years of menopause, it protects the heart; started twenty years out, it can harm it. Same drug, same dose โ€” the difference is whether the artery already has plaque. Early starters saw roughly half the coronary deaths and heart attacks 3, and a Danish trial following recently-menopausal women for a decade found about a fifty-percent drop in combined death, heart attack, and heart failure 4.

The breast-cancer risk depends on which hormones. Estrogen plus a synthetic progestin adds roughly one case per thousand women a year 5. Estrogen alone, after a hysterectomy, lowered breast cancer incidence and deaths 6.

It's one of the few drugs that has cut hip fractures in a low-risk population, by about a third while you take it 7.

This is prescription-only, and the decision turns on three things: your timing, your uterus, and your cardiovascular history. Walk in asking which route fits you, rather than whether you qualify.

If your GP hands back the boxed warning, a NAMS-certified menopause practitioner (the list is public) is the more reliable route 10.

Different effects run on different clocks.

  • Two to six weeks: hot flashes drop; you sleep through instead of waking drenched.
  • Four to twelve weeks: vaginal tissue rehydrates, sex stops hurting, recurrent urinary infections stop 9.
  • Three to six months: mood steadies and the fog lifts, mostly because you're sleeping again.
  • One to two years: the bone you were losing each year flattens 7. You won't feel it; the scan shows it.
The fine print โ€” when to skip it, and what people get wrong

Don't start with a personal history of breast or estrogen-sensitive cancer, blood clots, stroke, heart attack, active liver disease, or unexplained bleeding. Ten-plus years past menopause with no symptoms: the window for starting fresh has likely closed 11.

"You must stop at five years." NAMS threw that rule out; duration follows the risk-benefit 1. "Compounded bioidenticals are safer." They lack dose verification and under-deliver progesterone; FDA-approved estradiol is already bioidentical 1.

When it "didn't work": the dose was too low (titrate up), or the route was wrong for your clot risk (patch, not pill) 8. Don't stop cold; abrupt withdrawal flags excess cardiac deaths in the first year 12. Taper.

References
  1. 1NAMS (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. link
  2. 2MacLennan AH et al. (2004). Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews. link
  3. 3Boardman HM et al. (2015). Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews. link
  4. 4Schierbeck LL et al. (2012). Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. link
  5. 5Chlebowski RT et al. (2020). Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. JAMA. link
  6. 6Anderson GL et al. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. link
  7. 7Cauley JA et al. (2003). Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. link
  8. 8Canonico M et al. (2007). Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens (ESTHER study). Circulation. link
  9. 9NAMS (2020). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. link
  10. 10Manson JE et al. (2024). The Women's Health Initiative Randomized Trials and Clinical Practice: A Review. JAMA. link
  11. 11Rossouw JE et al. (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. link
  12. 12Mikkola TS et al. (2015). Increased cardiovascular mortality risk in women discontinuing postmenopausal hormone therapy. Journal of Clinical Endocrinology & Metabolism. link
ยท
638